Skip to main content

Table 2 Frequency of ESBL- and carbapenemase-associated mobile genetic elements among mucosa-associated E. coli and K. pneumoniea isolates from colonic biopsies of patients with IBD.

From: High prevalence of Mucosa-Associated extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD)

ESBL genes

IBD-related isolates

E. coli (MDR)

N = 68

 K. pneumoniae (MDR)

N = 23

n

%

n

%

blaCTX−M (n = 32)

27

(17)

39.7%

(25%)

5

(4)

21.7%

(17.3%)

blaSHV (n = 17)

11

(6)

16.1%

(8.8%)

6

(5)

26%

(21.7%)

blaTEM (n = 29)

20

(11)

29.4%

(16.1%)

9

(8)

39.1%

(34.7%)

blaVEB (n = 1)

1

(1)

1.8%

(1.8%)

-

-

blaGES (n = 0)

-

-

-

-

blaPER (n = 0)

-

-

-

-

CAP genes

    

blaNDM (n = 2)

1

(1)

1.8%

(1.8%)

2

(2)

12.5%

(12.5%)

blaKPC (n = 2)

-

-

3

(3)

13%

(13%)

blaDIM (n = 0)

-

-

-

-

blaIMP (n = 2)

1

(1)

1.8%

(1.8%)

1

(1)

6.2%

(6.2%)

blaVIM (n = 0)

-

-

-

-

blaSPM (n = 0)

-

-

-

-

  1. Abbreviations: CAP, carbapenemase; CD, Crohn’s disease; ESBL, extended-spectrum beta-lactamases; MDR, multidrug resistant; UC, ulcerative colitis